Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
News at 10 in a few minutes time...not much of an article but mentions a number of vaccine companies including those that have previously worked with Hvivo I believe....
Re. Vaccine trials...
Something brewing maybe? ITV news tonight someone from Imperial College London interviewed as part of a wider article on vaccines being ready and tested by six global vaccine producers. No direct mention of Hvivo, but as per the earlier articles from 23rd September Imperial College London involved as academic leaders connected to the Hvivo clinic....see previous report link below ...
I don't know quite what's changed today to push the SP up, but something appears to being on the cards in the way of an announcement maybe? Will we be getting a confirmation RNS on Covid 19 challenge contracts I wonder or something else as so many irons in the fire at the moment, Imutex, Pre-Biopharm, Venn Database, smart wearables etc etc...?
https://www.irishtimes.com/business/health-pharma/irish-company-to-test-vaccines-on-volunteers-deliberately-infected-with-covid-19-1.4362506
Could use your house as I can’t see you having anybody coming round lol, u asked for that .
They could use a cruise ship as their pretty empty at the moment lol....
Andi, don’t know why they don’t hire one of those nightingale wards as they’ve hardly been used , I know they’ve just said they might be used , but the government might be open to the idea lol.
https://www.ft.com/content/b782f666-6847-4487-986c-56d3f5e46c0b
and this....
The FT report said 1Day Sooner is launching a campaign this week to get public funding for a biocontainment facility for the studies, big enough to quarantine 100 to 200 volunteers.
Looks like there working on old news , that’s been well publicised , and we all know there’s an option of getting extra facilities , looking good
Like this bit of extract from the article;
Please use the sharing tools found via the share button at the top or side of articles. Copying articles to share with others is a breach of FT.com T&Cs and Copyright Policy. Email licensing@ft.com to buy additional rights. Subscribers may share up to 10 or 20 articles per month using the gift article service. More information can be found at https://www.ft.com/tour.
https://www.ft.com/content/b782f666-6847-4487-986c-56d3f5e46c0b
Volunteers who take part in hVivo’s influenza challenge studies receive up to £3,750 compensation. The payment for Covid-19 trials is likely to be somewhat higher because the isolation will last longer — potentially as long as a month.
The hVivo facility could be divided into three zones of eight beds each, to test three different vaccines at the same time. There is likely to be intense demand for its services and larger facilities may be opened later.
GLA